Recent Posts
- Providence Swedish Neuroscience Institute (PSNI) Reaches Milestone in Reducing Global Burden of Glioblastoma
- A New Approach to Treating Brain Cancer: HDT Bio Launches Canadian Clinical Program at McGill University
- HDT Bio and UTMB Receive MCDC Innovation Prototype Award for Advancing CCHF Vaccine from Lab to Phase 1 Clinical Trial
- FDA Greenlights HDT Bio’s First-in-Class HDT-321 for the Prevention of Deadly Tick-Borne Disease
- Institutional Biosafety Committee
Recent Comments
No comments to show.